What’s Driving the Boom in Early Stage Biotech Funding?
The LabTech website noted that J&J Innovation is one of the many investors that are turning their gaze to the promise of early-stage research. J&J Innovation is following a strategy focusing on supporting ‘open innovation’, an approach that they believe could work where the traditional pharma approach has failed. J&J entered a collaboration
Comments Off on What’s Driving the Boom in Early Stage Biotech Funding? • Read this story »
More Articles
Vetter Launches Open Innovation Challenge
The Pharmabiz website reported that Vetter Pharma International, a leading contract development and manufacturing organization, has launched the Open Innovation Challenge campaign to develop a future-focused and sustainable solutions for the injection of medicines. It is bringing together approximately
Comments Off on Vetter Launches Open Innovation Challenge • Read this story »
Europe has Untapped Medical Innovation
The PharmaPhorum website noted that the ‘open innovation’ strategy is being pursued by all the big pharma companies – and now it’s simply a matter of who executes best on this approach. This is one of the boldest efforts in big pharma to create relationships with entrepreneurs, scientists and
Comments Off on Europe has Untapped Medical Innovation • Read this story »
Collaborations Can Make UK a Pharma Leader
The Pharma Letter website reported that the move away from the older model of closed corporate research and development labs and towards collaborative working and open innovation is highlighted as in the R&D sourcebook from the Association of the British Pharmaceutical Industry (ABPI). “It is therefore
Comments Off on Collaborations Can Make UK a Pharma Leader • Read this story »
Radical Experiment Changing the Way Big Pharma Innovates
The Fortune website noted that in the highly competitive, IP-obsessed world of drug development, throwing open the doors and inviting people in, is a departure in strategy to say the least. Yet, such is the surprising concept behind JLABS, the “no strings attached” incubator that Johnson & Johnson
Comments Off on Radical Experiment Changing the Way Big Pharma Innovates • Read this story »
Open Innovation and Big Pharma
The PMLive website reported that there has been a major drive towards an open innovation model among big pharma companies, seeking to forge closer ties with small biopharma companies and academic groups in recognition that relying on in-house pharma R&D is no longer enough to remain competitive.
Comments Off on Open Innovation and Big Pharma • Read this story »
Joel West on Open Innovation
The Keck Graduate Institute website reported that Joel West, Henry Chesbrough and Wim Vanhaverbeck recently published a new book, “New Frontiers in Open Innovation.” In an interview with the site Dr. West discusses the approach the three open innovation experts took to covering the extensive
Comments Off on Joel West on Open Innovation • Read this story »
AstraZeneca Reinforces Pipeline With Open Innovation
The Telegraph website reported that big pharma giant AstraZeneca has spent the past few years forging partnerships with groups spanning health charities, academic researchers and even its industry rivals. The collaborations work by openly sharing early-stage research, mostly into understanding
Comments Off on AstraZeneca Reinforces Pipeline With Open Innovation • Read this story »
The Right Prescription: Open Innovation
The Business Standard website reported that the rising cost of drug discovery makes it pertinent to look at alternate models to approach innovation. The ‘Open Innovation model’ has emerged as an interesting alternative. It is based upon openness and collaboration, which is in complete
Comments Off on The Right Prescription: Open Innovation • Read this story »
Big companies Look to Open Innovation
The Financial Times reports that Unilever, the Anglo-Dutch conglomerate, is trawling the outside world for help in producing an environmentally friendly detergent and sugar-reduced drinks. The move is part of a growing global trend for open innovation
Comments Off on Big companies Look to Open Innovation • Read this story »